• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Oncology division





























Are we really having a meeting in October? If so, we each get 2 weeks off after the meeting for being exposed to Delta! Great plan. I'm making plans for my 2 weeks off.

Get vaccinated. Stop the complaining. You have a six figure plus job and may have to travel for the first time in a year and a half. Whaaaaaa
 
















If we have a meeting and someone gets it or has it, they have to tell us or risk law suites. Why jeopardize people right now. The snowflakes are already scared of their shadow.
 




























Clearly non of you understand that the ICAM's that moved into the ABL position were not promoted. They were already at the same level as the DSM's. This complete misunderstanding of the role and level of responsibility of the ICAM Team is part of the reason for this realignment. So the ICAM's that remain are now either managing a group of people that they have no interest in managing with no change in pay or struggling with having their career back tracked to an OSS albeit also at the same pay. Eisai will continue to wonder why they have excessive turnover and that is about to sky rocket even further. Leaders who don't want to lead and have limited training is a recipe for disaster for everyone. I can't wait for all the HR issues that are going to ensue. It's been said many times before. Eisai is absolutely right at the top of the list for worse places to work if you are in commercial sales. Why? Because this NJ based train wreck has little to no respect for field personnel.